Global Retinitis Pigmentosa Treatment & Management Market Size, Status and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 98

Report ID: 19991

Retinitis pigmentosa (RP) is a genetic disorder of the eyes that causes loss of vision.
Retinitis pigmentosa is generally inherited from a person's parents. Mutations in one of more than 50 genes is involved.
In 2018, the global Retinitis Pigmentosa Treatment & Management market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Retinitis Pigmentosa Treatment & Management status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Retinitis Pigmentosa Treatment & Management development in United States, Europe and China.

The key players covered in this study
ReNeuron
Amarantus BioScience
Ocugen
ReGenX Biosciences
Sucampo Pharmaceuticals
Orphagen Pharmaceuticals
Okuvision
Second Sight Medical

Market segment by Type, the product can be split into
Vitamin A
Docosahexaenoic Acid
Calcium Channel Blockers
Gene Therapy
Retinal Eye Prosthetics

Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Retinitis Pigmentosa Treatment & Management status, future forecast, growth opportunity, key market and key players.
To present the Retinitis Pigmentosa Treatment & Management development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Retinitis Pigmentosa Treatment & Management are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Retinitis Pigmentosa Treatment & Management Market Size Growth Rate by Type (2014-2025)
1.4.2 Vitamin A
1.4.3 Docosahexaenoic Acid
1.4.4 Calcium Channel Blockers
1.4.5 Gene Therapy
1.4.6 Retinal Eye Prosthetics
1.5 Market by Application
1.5.1 Global Retinitis Pigmentosa Treatment & Management Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Retinitis Pigmentosa Treatment & Management Market Size
2.2 Retinitis Pigmentosa Treatment & Management Growth Trends by Regions
2.2.1 Retinitis Pigmentosa Treatment & Management Market Size by Regions (2014-2025)
2.2.2 Retinitis Pigmentosa Treatment & Management Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Retinitis Pigmentosa Treatment & Management Market Size by Manufacturers
3.1.1 Global Retinitis Pigmentosa Treatment & Management Revenue by Manufacturers (2014-2019)
3.1.2 Global Retinitis Pigmentosa Treatment & Management Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Retinitis Pigmentosa Treatment & Management Market Concentration Ratio (CR5 and HHI)
3.2 Retinitis Pigmentosa Treatment & Management Key Players Head office and Area Served
3.3 Key Players Retinitis Pigmentosa Treatment & Management Product/Solution/Service
3.4 Date of Enter into Retinitis Pigmentosa Treatment & Management Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Retinitis Pigmentosa Treatment & Management Market Size by Type (2014-2019)
4.2 Global Retinitis Pigmentosa Treatment & Management Market Size by Application (2014-2019)

5 United States
5.1 United States Retinitis Pigmentosa Treatment & Management Market Size (2014-2019)
5.2 Retinitis Pigmentosa Treatment & Management Key Players in United States
5.3 United States Retinitis Pigmentosa Treatment & Management Market Size by Type
5.4 United States Retinitis Pigmentosa Treatment & Management Market Size by Application

6 Europe
6.1 Europe Retinitis Pigmentosa Treatment & Management Market Size (2014-2019)
6.2 Retinitis Pigmentosa Treatment & Management Key Players in Europe
6.3 Europe Retinitis Pigmentosa Treatment & Management Market Size by Type
6.4 Europe Retinitis Pigmentosa Treatment & Management Market Size by Application

7 China
7.1 China Retinitis Pigmentosa Treatment & Management Market Size (2014-2019)
7.2 Retinitis Pigmentosa Treatment & Management Key Players in China
7.3 China Retinitis Pigmentosa Treatment & Management Market Size by Type
7.4 China Retinitis Pigmentosa Treatment & Management Market Size by Application

8 Japan
8.1 Japan Retinitis Pigmentosa Treatment & Management Market Size (2014-2019)
8.2 Retinitis Pigmentosa Treatment & Management Key Players in Japan
8.3 Japan Retinitis Pigmentosa Treatment & Management Market Size by Type
8.4 Japan Retinitis Pigmentosa Treatment & Management Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Retinitis Pigmentosa Treatment & Management Market Size (2014-2019)
9.2 Retinitis Pigmentosa Treatment & Management Key Players in Southeast Asia
9.3 Southeast Asia Retinitis Pigmentosa Treatment & Management Market Size by Type
9.4 Southeast Asia Retinitis Pigmentosa Treatment & Management Market Size by Application

10 India
10.1 India Retinitis Pigmentosa Treatment & Management Market Size (2014-2019)
10.2 Retinitis Pigmentosa Treatment & Management Key Players in India
10.3 India Retinitis Pigmentosa Treatment & Management Market Size by Type
10.4 India Retinitis Pigmentosa Treatment & Management Market Size by Application

11 Central & South America
11.1 Central & South America Retinitis Pigmentosa Treatment & Management Market Size (2014-2019)
11.2 Retinitis Pigmentosa Treatment & Management Key Players in Central & South America
11.3 Central & South America Retinitis Pigmentosa Treatment & Management Market Size by Type
11.4 Central & South America Retinitis Pigmentosa Treatment & Management Market Size by Application

12 International Players Profiles
12.1 ReNeuron
12.1.1 ReNeuron Company Details
12.1.2 Company Description and Business Overview
12.1.3 Retinitis Pigmentosa Treatment & Management Introduction
12.1.4 ReNeuron Revenue in Retinitis Pigmentosa Treatment & Management Business (2014-2019)
12.1.5 ReNeuron Recent Development
12.2 Amarantus BioScience
12.2.1 Amarantus BioScience Company Details
12.2.2 Company Description and Business Overview
12.2.3 Retinitis Pigmentosa Treatment & Management Introduction
12.2.4 Amarantus BioScience Revenue in Retinitis Pigmentosa Treatment & Management Business (2014-2019)
12.2.5 Amarantus BioScience Recent Development
12.3 Ocugen
12.3.1 Ocugen Company Details
12.3.2 Company Description and Business Overview
12.3.3 Retinitis Pigmentosa Treatment & Management Introduction
12.3.4 Ocugen Revenue in Retinitis Pigmentosa Treatment & Management Business (2014-2019)
12.3.5 Ocugen Recent Development
12.4 ReGenX Biosciences
12.4.1 ReGenX Biosciences Company Details
12.4.2 Company Description and Business Overview
12.4.3 Retinitis Pigmentosa Treatment & Management Introduction
12.4.4 ReGenX Biosciences Revenue in Retinitis Pigmentosa Treatment & Management Business (2014-2019)
12.4.5 ReGenX Biosciences Recent Development
12.5 Sucampo Pharmaceuticals
12.5.1 Sucampo Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Retinitis Pigmentosa Treatment & Management Introduction
12.5.4 Sucampo Pharmaceuticals Revenue in Retinitis Pigmentosa Treatment & Management Business (2014-2019)
12.5.5 Sucampo Pharmaceuticals Recent Development
12.6 Orphagen Pharmaceuticals
12.6.1 Orphagen Pharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 Retinitis Pigmentosa Treatment & Management Introduction
12.6.4 Orphagen Pharmaceuticals Revenue in Retinitis Pigmentosa Treatment & Management Business (2014-2019)
12.6.5 Orphagen Pharmaceuticals Recent Development
12.7 Okuvision
12.7.1 Okuvision Company Details
12.7.2 Company Description and Business Overview
12.7.3 Retinitis Pigmentosa Treatment & Management Introduction
12.7.4 Okuvision Revenue in Retinitis Pigmentosa Treatment & Management Business (2014-2019)
12.7.5 Okuvision Recent Development
12.8 Second Sight Medical
12.8.1 Second Sight Medical Company Details
12.8.2 Company Description and Business Overview
12.8.3 Retinitis Pigmentosa Treatment & Management Introduction
12.8.4 Second Sight Medical Revenue in Retinitis Pigmentosa Treatment & Management Business (2014-2019)
12.8.5 Second Sight Medical Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details